A Phase II, Placebo-controlled Trial Evaluating the Efficacy of Antroquinonol in Patients With Atopic Dermatitis
Status:
Terminated
Trial end date:
2019-06-25
Target enrollment:
Participant gender:
Summary
Primary Objective:
To evaluate the activity of Antroquinonol in patients with atopic dermatitis.
Secondary Objective:
To assess the mechanism and cytokines change of Antroquinonol in patients with atopic
dermatitis.
Exploratory Objective:
To explore potential relationships between Antroquinonol exposure and safety and efficacy
endpoints.